Oral drug absorption enhancement by chitosan and its derivatives.

By Maya Thanou, J. Verhoef, H. Junginger. Advanced Drug Delivery Reviews, 2001

655 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Mechanisms of drug combinations: interaction and network perspectives (2009, background): “One is the enhanced absorption of antithrombotic low-molecular-weight heparin (LMWH) by chitosa”
Chitosan-based biomaterials for tissue engineering (2013, background): “Within the framework of these tests, chitosan has shown biocompatibility [9,45] and was notably approved by the Food and Drug Administration (FDA) for use in wound dressings [46].”
Polysaccharide hydrogels for modified release formulations. (2007, background): “[181] M.”
Chitosan—A versatile semi-synthetic polymer in biomedical applications (2011, background): “Chitosan is considered as being a non-toxic, biologically compatible polymer [96].”
Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications (2015, background): “Different drugs or vaccines were loaded in the microspheres, they were protected, especially drugs which are protein in nature, in the digestive tract [90] and absorbed through the paracellular route on the epithelial layer [91].”